Vera Therapeutics
VERA

Vera Therapeutics (VERA) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
WedbushMaintainedNeutral$34.00Aug 17, 2026
HC Wainwright & Co.MaintainedBuy$90.00 from $125.00Aug 12, 2026
WedbushMaintainedNeutral$34.00 from $43.00Aug 11, 2026
HC Wainwright & Co.MaintainedBuy$125.00 from $110.00Jul 8, 2026
GuggenheimMaintainedBuy$76.00 from $56.00Jul 8, 2026
TD CowenMaintainedBuy$78.00 from $73.00Jul 8, 2026
WedbushMaintainedNeutral$43.00 from $35.00Jul 8, 2026
B of A SecuritiesMaintainedBuy$70.00 from $65.00Jul 7, 2026
Evercore ISI GroupMaintainedOutperform$91.00 from $95.00May 15, 2026
Wolfe ResearchUpgradedPeer Perform → Outperform$88.00Mar 11, 2026
HC Wainwright & Co.MaintainedBuy$110.00 from $90.00Mar 2, 2026
JP MorganMaintainedOverweight$96.00 from $99.00Dec 19, 2025
Goldman SachsMaintainedBuy$95.00 from $55.00Dec 19, 2025
B of A SecuritiesMaintainedBuy$66.00 from $48.00Dec 19, 2025
WedbushMaintainedNeutral$33.00 from $23.00Dec 11, 2025
Evercore ISI GroupMaintainedOutperform$97.00 from $75.00Dec 8, 2025
TD CowenMaintainedBuy$73.00 from $60.00Dec 5, 2025
HC Wainwright & Co.MaintainedBuy$90.00 from $85.00Nov 10, 2025
JP MorganMaintainedOverweight$52.00 from $53.00Nov 7, 2025
B of A SecuritiesInitiated CoverageBuy$48.00Oct 16, 2025

Frequently asked questions

  • What is the latest analyst rating on VERA?

    On Aug 17, 2026, Wedbush maintained Vera Therapeutics at Neutral with a price target of $34.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.